Banner Image Banner Image

Investors
& Media

Events

Events

Upcoming Events

Upcoming Events
More events are coming soon.

Archived Events

Archived Events
Feb 28, 2024 at 8:30 AM EST
Q4 and Year-End 2023 Financial Results and Business Update
Jan 09, 2024 at 4:30 PM PST
42nd Annual J.P.Morgan Healthcare Conference
Nov 29, 2023 at 2:10 PM EST
6th Annual Evercore ISI HealthCONx Conference
Nov 06, 2023 at 3:10 PM EST
5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) Conference
Nov 01, 2023 at 8:30 AM EDT
TG Therapeutics Q3 2023 Financial Results and Business Update
Sep 26, 2023 at 12:25 PM EDT
Cantor Global Healthcare Conference 2023
Sep 11, 2023 at 10:30 AM EDT
H.C. Wainwright 25th Annual Global Investment Conference
Aug 01, 2023 at 8:30 AM EDT
TG Therapeutics Q2 2023 Financial Results and Business Update
Jun 07, 2023 at 11:30 AM EDT
Jefferies 2023 Healthcare Conference
May 09, 2023 at 3:00 PM PDT
Bank of America Securities Health Care Conference 2023
May 01, 2023 at 8:30 AM EDT
TG Therapeutics Q1 2023 Financial Results and Business Update
Feb 28, 2023 at 8:30 AM EST
TG Therapeutics Q4 and Year-End 2022 Financial Results and Business Update
Jan 09, 2023 at 9:45 AM PST / 12:45 PM EST
41st Annual J.P. Morgan Healthcare Conference
Dec 29, 2022 at 8:30 AM EST
TG Therapeutics BRIUMVI™ (ublituximab-xiiy) FDA Approval Call
View Additional Information
Dial in: 1-877-407-8029 (US) 1-201-689-8029 (Ex-US)
Nov 10, 2022 at 8:30 AM EST
TG Therapeutics Q3 2022 Financial Results and Business Update
Sep 12, 2022 at 7:00 AM EDT
H.C. Wainwright 24th Annual Global Investment Conference
Aug 08, 2022 at 8:30 AM EDT
TG Therapeutics Q2 2022 Financial Results and Business Update
May 24, 2022 at 7:00 AM EDT
H.C. Wainwright Global Investment Conference 2022
Apr 28, 2022 at 12:30 PM EDT
B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference
Apr 18, 2022 at 8:30 AM EDT
TG Regulatory Update Call
Mar 01, 2022 at 8:30 AM EST
TG Therapeutics Q4 and Year-End 2021 Financial Results and Business Update
Jan 27, 2022 at 10:00 AM EST
B. Riley Securities’ 2022 Oncology Conference
Jan 10, 2022 at 9:45 AM EST
40th Annual J.P. Morgan Healthcare Conference
Nov 30, 2021 at 8:30 AM EST
TG Therapeutics Regulatory Update Call
Nov 18, 2021 at 3:00 AM EST
Jefferies Virtual London Healthcare Conference
Nov 11, 2021 at 12:00 PM EST
B. Riley Securities’ Fall 2021 Growth BioTech Best Ideas Virtual Conference
Nov 04, 2021 at 8:30 AM EDT
TG Therapeutics Q3 2021 Earnings Call and Business Update
Oct 14, 2021 at 12:30 PM EDT
TG ECTRIMS Investor & Analyst Event
Sep 27, 2021 at 10:40 AM EDT
2021 Cantor Virtual Global Healthcare Conference
Sep 20, 2021 at 8:30 AM EDT
TG iwCLL Investor & Analyst Event
Sep 13, 2021 at 7:00 AM EDT
H.C. Wainwright 23rd Annual Global Investment Conference
Aug 02, 2021 at 8:30 AM EDT
TG Therapeutics Q2 2021 Earnings Call and Business Update
View Additional Information
In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics.
Jul 14, 2021 at 12:30 PM EDT
Ladenburg Thalmann 2021 Healthcare Conference
Jun 22, 2021 at 10:00 AM EDT
Raymond James Human Health Innovation Conference
Jun 08, 2021 at 1:20 PM EDT
Goldman Sachs 42nd Annual Global Healthcare Conference
Jun 01, 2021 at 2:00 PM EDT
Jefferies Virtual Healthcare Conference
May 10, 2021 at 8:30 AM EDT
TG Therapeutics Q1 2021 Earnings Call and Business Update
View Additional Information
Dial in phone numbers: 1-877-407-8029 (U.S.), 1-201-689-8029 (Ex-US)
Apr 28, 2021 at 9:00 AM EDT
B. Riley Securities’ Virtual Neuroscience Conference Webcast
Apr 16, 2021 at 8:30 AM EDT
ULTIMATE I & II Phase 3 Data Preview Call
View Additional Information

Key Opinion Leader Participants: 

  • Lawrence Steinman, MD, of Stanford University and the Global Study Chair for the ULTIMATE I & II Phase 3 trials
  • Edward J. Fox, MD, PhD, of Central Texas Neurology Consultants and Chair for the ublituximab Phase 2 trial
  • Enrique Alvarez, MD, PhD, of University of Colorado Medicine
Mar 09, 2021 at 7:00 AM EST
H.C. Wainwright Global Life Sciences Conference
Mar 02, 2021 at 8:30 AM EST
TG Therapeutics Fourth Quarter and Year End 2020 Update Call
View Additional Information
Attendees may also join via phone by dialing 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Fourth Quarter and Year End 2020 Update Call
Feb 08, 2021 at 8:30 AM EST
TG Therapeutics UKONIQ (umbralisib) FDA Approval Call
View Additional Information

In order to participate in the conference call, please call 1-877-407-8029 (U.S.)

1-201-689-8029 (outside the U.S.),

Conference Title: TG Therapeutics

Jan 20, 2021 at 10:00 AM EST
B. Riley Securities Oncology Investor Conference
Jan 12, 2021 at 2:00 PM EST
39th Annual J.P. Morgan Healthcare Conference
Dec 10, 2020 at 8:30 AM EST
TG Therapeutics ULTIMATE I & II Call
Dec 01, 2020 at 10:05 AM EST
Evercore ISI 3rd Annual HealthCONx Conference
Nov 17, 2020 at 7:20 PM GMT
Jefferies Virtual London Conference
Nov 05, 2020 at 8:45 AM EST
TG Therapeutics ASH Abstract Release Call
View Additional Information
Attendees may also join via phone by dialing 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics ASH Abstract Review Call.
Sep 16, 2020 at 10:40 AM EDT
Cantor Fitzgerald Global Healthcare Conference
Sep 14, 2020 at 1:30 PM EDT
H.C. Wainwright 22nd Annual Global Investment Conference
Aug 10, 2020 at 8:30 AM EDT
Second Quarter 2020 Earnings Results
Jun 18, 2020 at 3:40 PM EDT
Raymond James 2020 Human Health Innovation Conference
Jun 11, 2020 at 4:40 PM EDT
Goldman Sachs 41st Annual Global Healthcare Conference
Jun 03, 2020 at 10:00 AM EDT
Jefferies 2020 Healthcare Conference
May 05, 2020 at 8:30 AM EDT
Update Conference Call & Webcast
View Additional Information

CONFERENCE CALL INFORMATION: 
The Company will host a conference call today, Tuesday, May 5, 2020 at 8:30 AM ET to discuss the UNITY-CLL Phase 3 Trial. In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics.

Mar 03, 2020 at 8:00 AM EST
Fourth Quarter 2019 Earnings Results
Jan 16, 2020 at 8:00 AM PST
38th Annual J.P. Morgan Healthcare Conference
Dec 09, 2019 at 7:30 PM EST
TG THERAPEUTICS INVESTOR & ANALYST EVENT
Nov 20, 2019 at 11:20 AM GMT
Jefferies London Healthcare Conference
Nov 12, 2019 at 8:30 AM EST
Third Quarter 2019 Earnings Results
Oct 28, 2019 at 8:30 AM EDT
TG Therapeutics Update Call
Oct 02, 2019 at 4:10 PM EDT
2019 Cantor Global Healthcare Conference
Sep 24, 2019 at 11:00 AM EDT
Ladenburg Thalmann Healthcare Conference
Aug 09, 2019 at 8:30 AM EDT
Second Quarter 2019 Earnings Results
Jun 19, 2019 at 9:10 AM EDT
Raymond James Life Sciences and MedTech Conference
Jun 05, 2019 at 9:00 AM EDT
Jefferies 2019 Healthcare Conference
May 20, 2019
May 2019 Corporate Presentation
May 10, 2019 at 8:00 AM EDT
First Quarter 2019 Earnings Results
Apr 09, 2019 at 4:50 PM EDT
18th Annual Needham Healthcare Conference
Apr 01, 2019 at 12:00 PM EDT
TG Therapeutics AACR 2019 Data Review Call
View Additional Information

Participant / Guest (Toll-Free): 877-407-8029
Participant / Guest (Toll): 201-689-8029

Mar 13, 2019 at 11:20 AM EDT
Cowen 39th Annual Health Care Conference
Feb 28, 2019 at 8:30 AM EST
TG Therapeutics Update Call
View Additional Information

Participant / Guest (Toll-Free): 877-407-8029
Participant / Guest (Toll): 201-689-8029

Jan 10, 2019 at 1:00 PM EST
37th Annual J.P. Morgan Healthcare Conference
Dec 02, 2018 at 8:00 PM PST
TG Therapeutics December 2018 Investor & Analyst Event
View Additional Information

The event will take place at the Marriott Gaslamp in San Diego California. This event will also be broadcast via conference call. To access the conference line, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), and reference Conference Title: TG Therapeutics December 2018 Investor & Analyst Event.

Nov 09, 2018 at 8:30 AM EST
Third Quarter 2018 Earnings Results
Oct 11, 2018 at 1:30 PM EDT
TG Therapeutics ECTRIMS Data Review Call
View Additional Information

Teleconference Information:
Participant / Guest (Toll-Free): 877-407-8029
Participant / Guest (Toll): 201-689-8029
Conference Title: TG Therapeutics ECTRIMS Data Review Call

Oct 02, 2018 at 1:00 PM EDT
Ladenburg Thalmann 2018 Healthcare Conference
Oct 01, 2018 at 2:20 PM EDT
Cantor Fitzgerald Global Healthcare Conference
Sep 25, 2018 at 8:30 AM EDT
TG Therapeutics Update Call
View Additional Information

Teleconference Information:
Participant / Guest (Toll-Free): 877-407-8029
Participant / Guest (Toll): 201-689-8029
Conference Title: TG Therapeutics Update Call

Aug 07, 2018 at 4:30 PM EDT
Second Quarter 2018 Earnings Results
View Additional Information

Teleconference Information:
Participant / Guest (Toll-Free): 877-407-8029
Participant / Guest (Toll): 201-689-8029
Conference Title: TGTX Q2 2018 Earnings Call

Jun 07, 2018 at 10:30 AM EDT
Jefferies 2018 Global Healthcare Conference
Jun 03, 2018 at 8:15 PM EDT
TG Therapeutics Analyst & Investor Event
View Additional Information

Teleconference Information:
Participant / Guest (Toll-Free): 877-407-8029
Participant / Guest (Toll): 201-689-8029

May 08, 2018 at 8:30 AM EDT
First Quarter 2018 Earnings Results
Mar 28, 2018 at 4:00 PM EDT
Needham 17th Annual Healthcare Conference
Mar 12, 2018 at 1:30 PM EDT
Cowen 38th Annual Health Care Conference
Mar 08, 2018 at 8:30 AM EST
Fourth Quarter 2017 Earnings Results
Mar 06, 2018 at 2:50 PM EST
Raymond James & Associates' 39th Annual Institutional Investors Conference
Jan 11, 2018 at 7:30 AM PST
36th Annual J.P. Morgan Healthcare Conference
Dec 10, 2017 at 8:15 PM EST
TG Therapeutics Investor & Analyst Event
View Additional Information

This event will also be broadcast via conference call.  To access the conference line, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), and reference Conference Title: TG Therapeutics December 2017 Investor & Analyst Event. 

Nov 08, 2017 at 8:30 AM EST
Third Quarter 2017 Earnings Results
Nov 02, 2017 at 8:30 AM EDT
Post ECTRIMS-ACTRIMS Conference Call
View Additional Information

To participate in the conference call please dial 877-407-8029

Sep 26, 2017 at 2:30 PM EDT
Ladenburg Thalmann 2017 Healthcare Conference
Sep 25, 2017 at 1:50 PM EDT
Cantor Fitzgerald Global Healthcare Conference
Aug 09, 2017 at 8:30 AM EDT
Second Quarter 2017 Earnings Results
Jun 08, 2017 at 2:00 PM EDT
Jefferies 2017 Global Healthcare Conference
Jun 05, 2017 at 7:00 PM CDT
TG Therapeutics Analyst and Investor event June 2017
May 05, 2017 at 8:30 AM EDT
First Quarter 2017 Earnings Results
Mar 21, 2017 at 3:20 PM EDT
27th Annual Oppenheimer Healthcare Conference
Mar 14, 2017 at 3:00 PM PDT
29th Annual ROTH Conference
Mar 10, 2017 at 8:30 AM EST
Fourth Quarter 2016 Earnings Results
Mar 06, 2017 at 8:30 AM EST
TG Therapeutics Phase 3 GENUINE Positive Topline Data Call
View Additional Information

You may need to disable a pop-up blocker to access the webcast replay.

Feb 13, 2017 at 9:00 AM EST
Biotechnology Innovation Organization 2017 BIO CEO & Investor Conference
Jan 12, 2017 at 10:30 AM PST
35th Annual J.P. Morgan Healthcare Conference
Dec 05, 2016 at 8:00 PM PST
TG Therapeutics December Analyst & Investor Event
Nov 07, 2016 at 8:30 AM EST
Third Quarter 2016 Earnings Results
Oct 13, 2016 at 8:30 AM EDT
Update on the GENUINE Phase 3 Trial
Sep 27, 2016 at 11:30 AM EDT
Ladenburg Thalmann 2016 Healthcare Conference
Aug 08, 2016 at 8:30 AM EDT
Second Quarter 2016 Earnings Results
Jun 10, 2016 at 10:00 AM EDT
Jefferies 2016 Healthcare Conference
Jun 06, 2016 at 7:10 PM CDT
TG Therapeutics 2016 Investor & Analyst Event
May 10, 2016 at 4:30 PM EDT
TG Therapeutics First Quarter 2016 Financial Results and Business Update
Mar 15, 2016 at 3:30 PM PDT
28th Annual ROTH Conference
Mar 09, 2016 at 9:20 AM EST
Cowen and Company 36th Annual Health Care Conference
Mar 08, 2016 at 11:35 AM EST
Raymond James & Associates' 37th Annual Institutional Investors Conference
Mar 07, 2016 at 4:30 PM EST
TG Therapeutics Fourth Quarter 2015 Financial Results and Business Update
Feb 08, 2016 at 1:00 PM EST
18th Annual BIO CEO & Investor Conference
Jan 14, 2016 at 9:00 AM PST
34th Annual J.P. Morgan Healthcare Conference
Dec 07, 2015 at 8:00 PM EST
TG Therapeutics 2015 Investor & Analyst Event
View Additional Information

TG Therapeutics will also host a reception on Monday, December 7th, 2015 beginning at 7:45pm ET, with featured presentations beginning promptly at 8:00pm ET. The event will take place at the Hyatt Regency Orlando in the Bayhill 17/18 Room. This event will be webcast live and will be available on the Events page, located within the Investors & Media section of the Company's website at www.tgtherapeutics.com,as well as archived for future review. This event will also be broadcast via conference call. In order to access the conference line, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), and reference Conference Title: TG Therapeutics 2015 Investor & Analyst Event.

Nov 09, 2015 at 8:30 AM EST
TG Therapeutics Third Quarter 2015 Financial
Sep 29, 2015 at 9:00 AM EDT
Ladenburg Thalmann 2015 Healthcare Conference
Sep 09, 2015 at 3:00 PM EDT
Rodman & Renshaw Annual Global Investment Conference
Aug 10, 2015 at 8:30 AM EDT
TG Therapeutics Second Quarter 2015 Financial
Jun 03, 2015 at 4:30 PM EDT
Jefferies 2015 Healthcare Conference
May 31, 2015 at 6:15 PM CDT
TG THERAPEUTICS' 2015 ANALYST & INVESTOR EVENT
View Additional Information

SHERATON CHICAGO HOTEL & TOWERS
Event Room: Mayfair
301 E North Water Street, Chicago IL
Conference Call dial-in: U.S. & Canada:866.740.1260 Access Code: 4220276

May 06, 2015 at 8:40 AM EDT
Deutsche Bank 40th Annual Health Care Conference
May 05, 2015 at 8:00 AM EDT
TG Therapeutics First Quarter 2015 Financial
Apr 20, 2015
106th Annual Meeting of the American Association for Cancer Research (AACR)
Mar 12, 2015 at 8:30 AM EDT
TG Therapeutics Fourth Quarter 2014 Financial
Mar 09, 2015 at 3:00 PM PDT
27th Annual ROTH Conference
Mar 04, 2015 at 10:40 AM EST
Cowen and Company 35th Annual Health Care Conference
Feb 09, 2015 at 2:30 PM EST
17th Annual BIO CEO & Investor Conference
Jan 15, 2015 at 8:30 AM PST
33rd Annual J.P. Morgan Healthcare Conference
Dec 09, 2014 at 8:30 AM PST
Ublituximab, A Novel Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), In Combination With TGR-1202, A Next Generation Once Daily PI3k delta Inhibitor, Demonstrates Activity In Heavily Pre-Treated And High-Risk CLL And B-Cell Lymphoma
View Additional Information

Oral Session: 801
Session: 624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Indolent B-cell NHL and T-cell NHL
Date and Time: Tuesday, December 9, 2014 at 8:00am, during 7:30 - 9:00 AM PT Session
Location: West Building, 2005-2007-2018-202

Dec 08, 2014 at 10:45 PM EST
TG Therapeutics' 2014 Analyst & Investor Event
Dec 01, 2014 at 2:50 PM EST
2014 Deutsche Bank BioFEST
Nov 11, 2014 at 8:30 AM EST
TG Therapeutics Third Quarter 2014 Financial
Sep 09, 2014 at 1:15 PM EDT
16th Annual Rodman & Renshaw Global Investment Conference
Jul 22, 2014 at 8:30 AM EDT
TG Therapeutics Second Quarter 2014 Financial Results
Jun 24, 2014 at 4:30 PM EDT
JMP Securities Healthcare Conference
Jun 17, 2014 at 2:55 PM EDT
2014 Wells Fargo Healthcare Conference
May 13, 2014 at 8:30 AM EDT
TG Therapeutics First Quarter 2014 Financial
May 08, 2014 at 12:50 PM EDT
39th Annual Deutsche Bank Healthcare Conference
Mar 11, 2014 at 11:30 AM PDT
26th Annual ROTH Conference
Mar 06, 2014 at 8:30 AM EST
TG Therapeutics Fourth Quarter 2013 and Year-End 2013 Financial Results and Business Update
Feb 10, 2014 at 3:00 PM EST
16th Annual BIO CEO & Investor Conference
Jan 16, 2014 at 1:00 PM PST
32nd Annual J.P. Morgan Healthcare Conference